Privacy Shield Policy


NxStage Medical, Inc. (“NxStage”) recognizes and acknowledges current data protection laws in the European Union (“EU”), and has therefore adopted this Privacy Shield Policy (“Policy”) governing Personal Data transferred from NxStage operations, affiliates, agents, third party distributors, patients, customers, dialysis providers and nephrologists or other healthcare providers in the EU to NxStage operations in the United States (“U.S.”). This Policy sets forth the standards under which NxStage will treat such Personal Data.

NxStage participates in the EU-U.S. Privacy Shield Framework administered by the U.S. Department of Commerce and commits to subject to the Principles all Personal Data received from the EU in reliance on the Privacy Shield. NxStage’s participation in Privacy Shield is subject to investigation and enforcement by the Federal Trade Commission. For more information about the Privacy Shield Framework, including a list of companies that have certified to Privacy Shield, please visit the U.S. Department of Commerce’s website at


Data Subject” means the individual to whom any given EU Personal Data covered by this Policy refers.

EU Personal Data” or “Personal Data” means any information relating to an individual residing in the EU that can be used to identify that individual either on its own or in combination with other readily available data (e.g., the individual’s name, title, work location, home address, date of birth, compensation, benefits, or family members).

Sensitive Personal Data” means Personal Data regarding any of the following:

  • Health or medical condition;
  • Racial or ethnic origin;
  • Political opinions;
  • Religious or philosophical beliefs;
  • Trade union membership;
  • Sex life; or
  • Criminal convictions or indictments.


This Policy applies to the collection, use, and disclosure in the U.S. of all EU Personal Data transferred from countries in the EU to NxStage in the U.S. Where NxStage acts solely as an agent processing EU Personal Data under the direction of a third party, NxStage has no direct relationship with the Data Subjects whose Personal Data it processes, and for such Personal Data, NxStage instead may rely on such third parties to comply with the European legal requirements underlying the Privacy Shield Principles.

All employees of NxStage that have access to such EU Personal Data in the U.S. are responsible for conducting themselves in accordance with this Policy. Adherence by NxStage to this Policy may be limited to the extent required to meet legal, regulatory, governmental, or national security obligations, but EU Personal Data shall not be collected, used, or disclosed in a manner contrary to this policy without the prior written permission of NxStage’s Privacy Officer.

NxStage employees responsible for engaging third parties to handle EU Personal Data covered by this Policy on behalf of NxStage (e.g., temporary staff, independent contractors, sub-contractors, business partners, or vendors) are responsible for obtaining appropriate assurances that such third parties have an obligation to conduct themselves in accordance with the applicable provisions of this Policy, including any applicable contractual assurances required by Privacy Shield.

Failure of a NxStage employee to comply with this Policy may result in disciplinary action up to and including termination.


NxStage has adopted the U.S. Department of Commerce’s Privacy Shield Principles, as set forth below, with respect to the EU Personal Data described in the “SCOPE AND RESPONSIBILITY” section of this Policy that is transferred from NxStage operations in the EU to NxStage operations in the U.S.

Notice – NxStage takes steps so that Data Subjects covered by this Policy are notified about the types of Personal Data it collects about them, the purposes for which it uses such Personal Data, the types of third parties to which it discloses such Personal Data, the choices and means that it offers for limiting its use and disclosure of such Personal Data, and how Data Subjects can contact NxStage with any inquiries or complaints. Notice is provided in clear and conspicuous language at the time of collection or as soon as practicable thereafter; before NxStage uses or discloses Personal Data for a purpose other than that for which it was originally collected, and through this Policy.

Specifically, NxStage collects and uses Personal Data for, among other things:

  1. the delivery of current and future products and services;
  2. compliance as required by law, or as permitted by law;
  3. our everyday business operations such as:
    • product safety and product complaint reporting;
    • patient assistance;
    • communicating information about diseases, products and services, or via e-mail, direct mail and other channels;
    • business and marketing research; and
    • auditing our programs and resources for compliance and security purposes; and
  4. Employment related purposes and legitimate human resource business reasons such as:
    • carrying out and supporting its human resources functions and activities;
    • carrying out its obligations under employment contracts and employment and benefits laws;
    • administering employee participation in benefits, compensation and human resources plans and programs;
    • managing employee performance;
    • implementing compliance and discipline procedures, and investigating and reporting on employee compliance and discipline; and
    • complying with legal or contractual obligations, carrying out investigations and for other internal administrative purposes.

NxStage discloses Personal Data to the following types of third parties:

  • To third parties that are designated by the Data Subject or customer to which the Personal Data pertains for purposes of providing health care treatment (including training and service), paying for health care, or for the administrative health care operations of a health plan or health care provider;
  • To NxStage affiliates or subsidiaries for purposes such as coordinating the delivery of products or services, processing payment and conducting data analytics;
  • To agents, distributors or third party service providers (such as accountants, attorneys, consultants, and other service providers) who need the information in order to provide services to or perform activities on behalf of NxStage, including in connection with the delivery of services or products, NxStage’s management, administration, or legal responsibilities; or
  • As required by law, including disclosure in response to lawful requests by public authorities, such as to meet national security or law enforcement requirements.

In addition, NxStage collects, uses, and discloses Personal Data collected from users of NxStage’s public website as described in the privacy policy, available at

Choice – In the event EU Personal Data covered by this Policy is to be used for a new purpose that is materially different from the purpose(s) for which the Personal Data was originally collected or subsequently authorized, or is to be transferred to the control of a third party, Data Subjects are given, when feasible and appropriate, an opportunity to choose (opt-out) whether to have their Personal Data so used or transferred. In the event that Sensitive Personal Data is used for a new purpose or transferred to the control of a third party, the Data Subject’s explicit consent (opt-in) will be obtained prior to such use or transfer of the Sensitive Personal Data.

Accountability for Onward Transfer (transfers to affiliates and/or other third parties) – In the event NxStage transfers EU Personal Data covered by this Policy to an affiliate or other third party, it will do so consistent with any notice provided to Data Subjects and any consent they have given. NxStage will transfer Personal Data to such third parties only if the transfer is for limited and specified purposes and the third party will provide at least the same level of privacy protection as is required by this Policy and the Privacy Shield Principles. When NxStage has knowledge that a third party is using or sharing Personal Data in a way that is contrary to this Policy, NxStage will take reasonable steps to prevent or stop such use or sharing.

With respect to transfers to its agents, NxStage remains responsible under the Privacy Shield Principles if an agent processes Personal Data in a manner inconsistent with the Principles, except where NxStage is not responsible for the event giving rise to the damage.

Access – Data Subjects whose Personal Data is covered by this Policy have the right to access such Personal Data and to correct, amend, or delete such Personal Data if they can demonstrate that it is inaccurate or incomplete (except when the burden or expense of providing access, correction, amendment, or deletion would be disproportionate to the risks to the Data Subject’s privacy, or where the rights of persons other than the Data Subject would be violated).

Security – NxStage takes reasonable precautions to protect EU Personal Data covered by this Policy from loss, misuse, and unauthorized access, disclosure, alteration, and destruction.

Data Integrity and Purpose Limitation – EU Personal Data covered by this Policy that is collected, processed, and maintained by NxStage shall be kept and used for its intended purpose. NxStage takes reasonable steps to ensure that the Personal Data is used for its intended purpose(s), and is accurate, complete, and current.

Recourse, Enforcement, and Liability – To ensure compliance with these Privacy Shield Principles, NxStage will:

  • In the investigation and resolution of complaints that cannot be resolved between NxStage and the complainant, cooperate with and comply with the dispute resolutions mechanisms of:
    • For HR Personal Data, a panel established by the EU Data Protection Authorities (“DPAs”); and
    • For non-HR Personal Data, if you have an unresolved privacy or data use concern that we have not addressed satisfactorily, please contact our U.S.-based third party dispute resolution provider (free of charge) at
  • Periodically review and verify its compliance with the Privacy Shield Principles; and
  • Remedy issues arising out of any failure to comply with the Privacy Shield Principles.

NxStage acknowledges that its failure to provide an annual self-certification to the U.S. Department of Commerce will remove it from the Department’s list of Privacy Shield participants, and thereafter transfers of Personal Data will not be allowed unless NxStage otherwise complies with EU data protection law.


Any inquiries or complaints regarding this Policy or the collection, use, disclosure, or transfer of Personal Data should be directed to the Privacy Officer of NxStage Medical, Inc., who may be contacted at 920 Winter Street, Waltham, MA 02451, or to Mr. Michael Read, Fresenius Medical Care UK Ltd., Nunn Brook Road, Huthwaite, Sutton-in-Ashfield, Nottinghamshire NG17 2HU, United Kingdom. NxStage will investigate and attempt to resolve complaints in accordance with the Privacy Shield Principles. In the event an inquiry or complaint cannot be resolved between NxStage and a Data Subject, the Data Subject may contact an independent recourse mechanism to provide appropriate recourse free of charge:

  • For inquiries or complaints regarding HR Personal Data, the DPA of the EU Member State where the Data Subject works, which can refer the complaint to the DPA panel; or
  • For inquiries or complaints regarding non-HR Personal Data, if you have an unresolved privacy or data use concern that we have not addressed satisfactorily, please contact our U.S.-based third party dispute resolution provider (free of charge) at

Should a complaint remain fully or partially unresolved after a review by NxStage and the applicable independent recourse mechanism, Data Subjects may be able to, under certain conditions, seek binding arbitration before the Privacy Shield Panel. For more information, please visit


This Policy may be amended from time to time consistent with the requirements of the Privacy Shield Principles. Appropriate notice will be given concerning such amendments.

Effective: September 2016, Revised effective August 2019


APM2192-ENG Rev. B

Fresenius Medical Care has successfully completed its merger with NxStage Medical, Inc.

More Info